Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study
Abstract Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy, recently classified in small duct and large duct morphological subtypes. Growing evidence suggests asbestos as a putative risk factor for iCCA, albeit no correlation between asbestos and iCCA morphology has been investigated so fa...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | Francesco Vasuri, Marzia Deserti, Angelo G. Corradini, Simona Tavolari, Valeria Relli, Andrea Palloni, Giorgio Frega, Stefania Curti, Stefano Mattioli, Matteo Cescon, Antonia D’Errico, Giovanni Brandi |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-02-01
|
| Online Access: | https://doi.org/10.1038/s41598-023-27791-1 |
Similar Items
Asbestos and Intrahepatic Cholangiocarcinoma
by: Giovanni Brandi, et al.
Published: (2020-02-01)
by: Giovanni Brandi, et al.
Published: (2020-02-01)
Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link
by: Giovanni Brandi, et al.
Published: (2022-06-01)
by: Giovanni Brandi, et al.
Published: (2022-06-01)
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
by: Giovanni Brandi, et al.
Published: (2024-02-01)
by: Giovanni Brandi, et al.
Published: (2024-02-01)
Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma
by: Chiara Deiana, et al.
Published: (2025-03-01)
by: Chiara Deiana, et al.
Published: (2025-03-01)
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
by: Giovanni Brandi, et al.
Published: (2023-04-01)
by: Giovanni Brandi, et al.
Published: (2023-04-01)
Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01)
by: Hoon Hur, et al.
Published: (2009-01-01)
Cholangiocarcinoma and pleural mesothelioma: asbestos exposure as a shared risk factor? A comparison of age-standardized incidence rates in Italy
by: Mena Gallo, et al.
Published: (2022-01-01)
by: Mena Gallo, et al.
Published: (2022-01-01)
Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma
by: Cristina Nanni, et al.
Published: (2023-07-01)
by: Cristina Nanni, et al.
Published: (2023-07-01)
Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review
by: Simona Tavolari, et al.
Published: (2023-04-01)
by: Simona Tavolari, et al.
Published: (2023-04-01)
Endoscopic Palliation of Hilar Cholangiocarcinoma: Usefulness of Selective Occlusion of One Intrahepatic Duct
by: João Fernandes, et al.
Published: (2019-06-01)
by: João Fernandes, et al.
Published: (2019-06-01)
Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)
Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma
by: Romina Mancinelli, et al.
Published: (2020-10-01)
by: Romina Mancinelli, et al.
Published: (2020-10-01)
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
by: Angela Dalia Ricci, et al.
Published: (2020-08-01)
by: Angela Dalia Ricci, et al.
Published: (2020-08-01)
Molecular and Pathological Heterogeneity of Synchronous Small and Large Duct Intrahepatic Cholangiocarcinoma—A Case Series
by: Savelina Popovska, et al.
Published: (2025-04-01)
by: Savelina Popovska, et al.
Published: (2025-04-01)
Small duct type intrahepatic cholangiocarcinoma with extensive intraductal extension mimics an intraductal tubulopapillary neoplasm
by: Mark Fowler, et al.
Published: (2023-03-01)
by: Mark Fowler, et al.
Published: (2023-03-01)
Cholangiocarcinoma of intrahepatic bile ducts with disseminated metastases in a Siamese cat: a case report
by: O. Aslan, et al.
Published: (2014-07-01)
by: O. Aslan, et al.
Published: (2014-07-01)
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
by: Kyoung-Bun Lee
Published: (2016-09-01)
by: Kyoung-Bun Lee
Published: (2016-09-01)
A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach
by: Hongwei Qian, et al.
Published: (2025-03-01)
by: Hongwei Qian, et al.
Published: (2025-03-01)
Radiomics and radiogenomics in intrahepatic cholangiocarcinoma
by: A. D. Smirnova, et al.
Published: (2024-03-01)
by: A. D. Smirnova, et al.
Published: (2024-03-01)
Conversion therapy of intrahepatic cholangiocarcinoma
by: Wang Zhiwei, et al.
Published: (2020-12-01)
by: Wang Zhiwei, et al.
Published: (2020-12-01)
SARCOMATOID CHANGE IN INTRAHEPATIC CHOLANGIOCARCINOMA
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)
by: Wewer Albrechtsen, et al.
Published: (2013-01-01)
Sarcomatoid change in intrahepatic cholangiocarcinoma
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)
by: Albrechtsen Wewer Nicolai, et al.
Published: (2013-03-01)
Diagnosis of intrahepatic cholangiocarcinoma with CEUS
by: Velardi Giancarlo Gismondo, et al.
Published: (2024-02-01)
by: Velardi Giancarlo Gismondo, et al.
Published: (2024-02-01)
Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)
by: Yoshiyuki Inoue, et al.
Published: (2012-01-01)
Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
by: Gennaro Gadaleta-Caldarola, et al.
Published: (2022-10-01)
by: Gennaro Gadaleta-Caldarola, et al.
Published: (2022-10-01)
Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection
by: Bingqi Ma, et al.
Published: (2021-01-01)
by: Bingqi Ma, et al.
Published: (2021-01-01)
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center
by: Alessandro Rizzo, et al.
Published: (2022-07-01)
by: Alessandro Rizzo, et al.
Published: (2022-07-01)
Advances in surgical treatment of intrahepatic cholangiocarcinoma
by: LIU Shenyang, TANG Zhaohui, QUAN Zhiwei
Published: (2022-05-01)
by: LIU Shenyang, TANG Zhaohui, QUAN Zhiwei
Published: (2022-05-01)
Prognostic factors in patients with intrahepatic cholangiocarcinoma
by: Yun-Jau Chang, et al.
Published: (2024-08-01)
by: Yun-Jau Chang, et al.
Published: (2024-08-01)
The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
by: Oraianthi Fiste, et al.
Published: (2021-04-01)
by: Oraianthi Fiste, et al.
Published: (2021-04-01)
The focus clinical research in intrahepatic cholangiocarcinoma
by: Yinghui Song, et al.
Published: (2022-07-01)
by: Yinghui Song, et al.
Published: (2022-07-01)
Effect of age on the prognosis of intrahepatic cholangiocarcinoma
by: Jung Hun Kim, et al.
Published: (2023-01-01)
by: Jung Hun Kim, et al.
Published: (2023-01-01)
PAUCITY OF INTRAHEPATIC BILE DUCTS
by: O. E. Iryshkin, et al.
Published: (2013-05-01)
by: O. E. Iryshkin, et al.
Published: (2013-05-01)
Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
by: Peipei Song, et al.
Published: (2019-10-01)
by: Peipei Song, et al.
Published: (2019-10-01)
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis
by: Ingrid Garajová, et al.
Published: (2023-02-01)
by: Ingrid Garajová, et al.
Published: (2023-02-01)
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma
by: Andrea Palloni, et al.
Published: (2023-05-01)
by: Andrea Palloni, et al.
Published: (2023-05-01)
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
by: Ingrid Garajová, et al.
Published: (2023-11-01)
by: Ingrid Garajová, et al.
Published: (2023-11-01)
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis
by: Francesco Tovoli, et al.
Published: (2020-10-01)
by: Francesco Tovoli, et al.
Published: (2020-10-01)
The clinical value of regional lymphadenectomy for intrahepatic cholangiocarcinoma
by: Facai Yang, et al.
Published: (2022-01-01)
by: Facai Yang, et al.
Published: (2022-01-01)
Preoperative chemotherapy usage experience for intrahepatic cholangiocarcinoma
by: A. N. Polyakov, et al.
Published: (2023-03-01)
by: A. N. Polyakov, et al.
Published: (2023-03-01)
Similar Items
-
Asbestos and Intrahepatic Cholangiocarcinoma
by: Giovanni Brandi, et al.
Published: (2020-02-01) -
Exposure to Asbestos and Increased Intrahepatic Cholangiocarcinoma Risk: Growing Evidences of a Putative Causal Link
by: Giovanni Brandi, et al.
Published: (2022-06-01) -
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
by: Giovanni Brandi, et al.
Published: (2024-02-01) -
Case Report: Long lasting response with TKI for combined hepatocellular-cholangiocarcinoma
by: Chiara Deiana, et al.
Published: (2025-03-01) -
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue
by: Giovanni Brandi, et al.
Published: (2023-04-01)
